1. Home
  2. FHTX vs BPRN Comparison

FHTX vs BPRN Comparison

Compare FHTX & BPRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • BPRN
  • Stock Information
  • Founded
  • FHTX 2015
  • BPRN 2007
  • Country
  • FHTX United States
  • BPRN United States
  • Employees
  • FHTX N/A
  • BPRN N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • BPRN Major Banks
  • Sector
  • FHTX Health Care
  • BPRN Finance
  • Exchange
  • FHTX Nasdaq
  • BPRN Nasdaq
  • Market Cap
  • FHTX 237.4M
  • BPRN 227.6M
  • IPO Year
  • FHTX 2020
  • BPRN N/A
  • Fundamental
  • Price
  • FHTX $4.10
  • BPRN $32.41
  • Analyst Decision
  • FHTX Strong Buy
  • BPRN Strong Buy
  • Analyst Count
  • FHTX 6
  • BPRN 1
  • Target Price
  • FHTX $13.17
  • BPRN $35.00
  • AVG Volume (30 Days)
  • FHTX 110.9K
  • BPRN 7.3K
  • Earning Date
  • FHTX 03-06-2025
  • BPRN 01-28-2025
  • Dividend Yield
  • FHTX N/A
  • BPRN 3.73%
  • EPS Growth
  • FHTX N/A
  • BPRN N/A
  • EPS
  • FHTX N/A
  • BPRN 1.55
  • Revenue
  • FHTX $25,515,000.00
  • BPRN $69,578,000.00
  • Revenue This Year
  • FHTX N/A
  • BPRN N/A
  • Revenue Next Year
  • FHTX $7.37
  • BPRN $12.33
  • P/E Ratio
  • FHTX N/A
  • BPRN $20.74
  • Revenue Growth
  • FHTX N/A
  • BPRN 0.35
  • 52 Week Low
  • FHTX $2.81
  • BPRN $29.02
  • 52 Week High
  • FHTX $10.25
  • BPRN $39.35
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 38.20
  • BPRN 45.23
  • Support Level
  • FHTX $3.89
  • BPRN $30.35
  • Resistance Level
  • FHTX $4.64
  • BPRN $33.36
  • Average True Range (ATR)
  • FHTX 0.34
  • BPRN 0.70
  • MACD
  • FHTX 0.07
  • BPRN -0.01
  • Stochastic Oscillator
  • FHTX 30.77
  • BPRN 58.19

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

Share on Social Networks: